A triple receptor tyrosine kinase inhibitor, blocking signaling through VEGFR (IC50 = 13-34 nM), PDGFR (IC50 = 59-65 nM), and FGFR (IC50 = 37-610 nM); inhibits angiogenesis; has potential applications in various forms of cancer and pulmonary fibrosis.